© 2021 MJH Life Sciences and Neurology Live. All rights reserved.
© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.
CORNING MEDICAL ASSOCIATES INC
155 SOLANO ST
May 11, 2015
PACAP38 is a potent aggravator of migraine, a new study shows. This provides several new potential therapeutic targets -- most prominently a specific PACAP receptor PAC1.
May 05, 2015
Intriguing research is helping to shape our understanding of the functional connectivity and brain structure of migraineurs.
April 23, 2015
Highlights of the first large study to describe the characteristics of post-traumatic headache and treatment response in children are summarized here.
A novel drug-device may not only be a promising non-oral triptan acute migraine treatment, but may be more efficacious than its oral counterpart.